Angelalign Technology Inc. (HKG: 6699)
Hong Kong
· Delayed Price · Currency is HKD 57.95
-0.95 (-1.61%)
Jan 2, 2025, 4:08 PM HKT
Angelalign Technology Revenue
Angelalign Technology had revenue of 861.50M CNY in the half year ending June 30, 2024, with 50.89% growth. This brings the company's revenue in the last twelve months to 1.72B, up 30.87% year-over-year. In the year 2023, Angelalign Technology had annual revenue of 1.48B with 16.24% growth.
Revenue (ttm)
1.72B CNY
Revenue Growth
+30.87%
P/S Ratio
5.04
Revenue / Employee
596.99K CNY
Employees
2,883
Market Cap
9.42B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 26.04B |
| Hansoh Pharmaceutical Group Company | 13.00B |
| JD Health International | 58.84B |
| WuXi Biologics | 18.39B |
| Sinopharm Group | 634.32B |
| Innovent Biologics | 8.01B |
| Sino Biopharmaceutical | 29.86B |
| CSPC Pharmaceutical Group | 33.53B |